1 – 10 of 2261
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance : Insights from the iStopMM study
(
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance and the risk of thrombotic events : Results from iStopMM, a prospective population-based screening study
(
- Contribution to journal › Article
-
Mark
BAY 81-8973 Demonstrates Long-Term Safety and Efficacy in Children With Severe Haemophilia A : Results From the LEOPOLD Kids Extension Study
(
- Contribution to journal › Article
-
Mark
Peripheral T- and natural killer-cell lymphomas : ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
(
- Contribution to journal › Article
-
Mark
The Swedish Society of Paediatric Infectious Diseases' 2025 Recommendations for the Initial Management of Suspected Paediatric Sepsis With or Without Shock
2025) In Acta Pædiatrica(
- Contribution to journal › Scientific review
-
Mark
Proteomic Profiling of Acoustically Isolated Extracellular Vesicles from Blood Plasma during Murine Bacterial Sepsis
(
- Contribution to journal › Article
-
Mark
Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden : LYMPHOMA
(
- Contribution to journal › Letter
-
Mark
New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis
(
- Contribution to journal › Article
-
Mark
Intracranial hemorrhage before start of prophylaxis in children with hemophilia : incidence, timing, and potential for prevention
(
- Contribution to journal › Article
-
Mark
A plain language summary on indirectly comparing bleeding after valoctocogene roxaparvovec gene therapy to bleeding with emicizumab prophylaxis
(
- Contribution to journal › Article